Chuan Xu

4.9k total citations
124 papers, 3.1k citations indexed

About

Chuan Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chuan Xu has authored 124 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 40 papers in Oncology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chuan Xu's work include RNA modifications and cancer (12 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Chuan Xu is often cited by papers focused on RNA modifications and cancer (12 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Chuan Xu collaborates with scholars based in China, United States and Taiwan. Chuan Xu's co-authors include Xiu‐Wu Bian, Hui‐Kuan Lin, You‐Hong Cui, Hong Wu, Guoxiang Jin, Cheng Qian, Senlin Xu, Shi‐Cang Yu, Weiqun Shu and Zhiqun Qiu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Chuan Xu

119 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan Xu China 29 1.7k 761 760 407 348 124 3.1k
Sujatha Venkataraman United States 36 2.2k 1.3× 790 1.0× 521 0.7× 211 0.5× 319 0.9× 85 3.3k
Alois Kozubı́k Czechia 37 2.2k 1.3× 839 1.1× 863 1.1× 393 1.0× 388 1.1× 160 4.0k
Mei Wang China 34 2.4k 1.5× 718 0.9× 617 0.8× 233 0.6× 331 1.0× 146 4.0k
Peng Hou China 41 3.3k 1.9× 1.1k 1.5× 1.3k 1.7× 429 1.1× 618 1.8× 177 5.7k
Zhuchu Chen China 34 2.7k 1.6× 779 1.0× 836 1.1× 336 0.8× 339 1.0× 166 3.7k
Li Fu China 32 1.5k 0.9× 963 1.3× 917 1.2× 323 0.8× 210 0.6× 119 2.8k
Peeter Karihtala Finland 28 1.7k 1.0× 584 0.8× 908 1.2× 389 1.0× 285 0.8× 126 3.0k
Daniel C. Flynn United States 33 2.1k 1.3× 526 0.7× 529 0.7× 408 1.0× 240 0.7× 69 3.6k
Zhuo Zhang China 30 1.9k 1.1× 785 1.0× 1.6k 2.1× 305 0.7× 534 1.5× 99 3.5k
Sophia Y. Lunt United States 20 2.2k 1.3× 1.5k 2.0× 483 0.6× 409 1.0× 232 0.7× 47 3.5k

Countries citing papers authored by Chuan Xu

Since Specialization
Citations

This map shows the geographic impact of Chuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Xu more than expected).

Fields of papers citing papers by Chuan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Xu. The network helps show where Chuan Xu may publish in the future.

Co-authorship network of co-authors of Chuan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Xu. A scholar is included among the top collaborators of Chuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Xu. Chuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yi, Yong, Wenhua Zhang, Junjie Fei, et al.. (2025). Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation. Nature Communications. 16(1). 212–212. 10 indexed citations
3.
Wu, Mengwan, et al.. (2024). Exosome‐transmitted podoplanin promotes tumor‐associated macrophage‐mediated immune tolerance in glioblastoma. CNS Neuroscience & Therapeutics. 30(3). e14643–e14643. 8 indexed citations
4.
Wu, Hong, Yiqiang Liu, Zhaoshen Li, et al.. (2024). HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing. Science Advances. 10(23). eadl6083–eadl6083. 8 indexed citations
5.
Shu, Chi, Qian Yang, Jun Huang, et al.. (2024). Pretreatment plasma vitamin D and response to neoadjuvant chemotherapy in breast cancer: evidence from pooled analysis of cohort studies. International Journal of Surgery. 110(12). 8126–8135. 7 indexed citations
7.
Song, Da, Fuqing Hu, Changsheng Huang, et al.. (2023). Tiam1 methylation by NSD2 promotes Rac1 signaling activation and colon cancer metastasis. Proceedings of the National Academy of Sciences. 120(52). e2305684120–e2305684120. 9 indexed citations
8.
Xing, Wei, Chin Wen Png, Heng Li, et al.. (2023). Tumor Promoting Function of DUSP10 in Non-Small Cell Lung Cancer Is Associated With Tumor-Promoting Cytokines. Immune Network. 23(4). e34–e34. 3 indexed citations
9.
Zhou, Wenjie, et al.. (2022). Trans-radial versus trans-femoral approach for cerebral angiography: a meta-analysis of randomized controlled trials.. Videosurgery and Other Miniinvasive Techniques. 18(2). 235–243. 2 indexed citations
10.
Liu, Mingxin, Hong Wu, & Chuan Xu. (2022). Targeting cancer stem cell pathways for lung cancer therapy. Current Opinion in Oncology. 35(1). 78–85. 11 indexed citations
11.
Liu, Yuyang, et al.. (2022). Comprehensive analysis of HHV‐6 and HHV‐7‐related gene signature in prognosis and response to temozolomide of glioma. Journal of Medical Virology. 95(1). e28285–e28285. 3 indexed citations
12.
Luo, D. W., H. y. Wu, Zhihuan Li, et al.. (2021). Performance of digital data acquisition system in gamma-ray spectroscopy. Nuclear Science and Techniques. 32(8). 10 indexed citations
13.
Zhu, Yajie, Chuan Xu, Shuya He, et al.. (2021). Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival. Leukemia Research. 111. 106688–106688. 4 indexed citations
14.
Chen, Xin, et al.. (2019). Design and Preliminary Experience of a Tele-Radiotherapy System for a Medical Alliance in China. Telemedicine Journal and e-Health. 26(2). 235–243. 10 indexed citations
15.
Zhang, Xian, Chien‐Feng Li, Ling Zhang, et al.. (2016). TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression. Molecular Cell. 64(4). 803–814. 63 indexed citations
17.
Wang, Bin, Qiang Wang, Zhe Wang, et al.. (2014). Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells. Cancer Research. 74(20). 5746–5757. 174 indexed citations
18.
Shi, Yu, Cong Chen, Qing Liu, et al.. (2014). Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma. Clinical Cancer Research. 20(7). 1803–1813. 81 indexed citations
19.
Xu, Chuan, Dan Xie, Shi‐Cang Yu, et al.. (2013). β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma. Cancer Research. 73(10). 3181–3189. 79 indexed citations
20.
Chen, Jian, Jiaohua Luo, Zhiqun Qiu, et al.. (2007). PCDDs/PCDFs and PCBs in water samples from the Three Gorge Reservoir. Chemosphere. 70(9). 1545–1551. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026